Global Preterm Birth Prevention and Management Market Things to Focus on to Ensure Long-term Success | Anglo French Drugs & Industries Limited, Biophar Lifesciences Pvt. Ltd., Jasco Labs (P) Ltd., BSA Pharma Inc. and Others
Preterm birth is also referred as premature birth of a baby. Preterm birth is considered when a baby is born fewer than 37 weeks gestational age. These babies are known as preemies or premmies. A developing baby undergoes through crucial growth process throughout the pregnancy including the final month. During the last month of pregnancy the brain, lungs, and liver fully develops. If babies are born too early than the desired time period of pregnancy, it creates high chances the disability for the baby.
Preterm birth is sub-categories in three stages based on gestational age viz. extremely preterm (less than 28 weeks), very preterm (28 to 32 weeks), moderate to late preterm (32 to 37 weeks). Preterm birth occurs due to various reasons but the multiple pregnancies, infections and chronic conditions such as diabetes and high blood pressure are the common cause of preterm birth. Some cause of preterm birth might be the genetic influence and some are still unidentified.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6457
Preterm Birth Prevention and Management Market: Drivers and Restraints
WHO has estimated that every year 15 million babies are born preterm which is the primary factor responsible for the growth of preterm prevention and management market. Preterm birth is also the leading cause of death among the children under 5 years of age, responsible for approximately 1 million deaths in 2015. Beside than increasing awareness by various NGO about women healthcare during the pregnancy will propel the growth of preterm birth prevention and management market.
Hospitals are frequently organizing awareness programme to use the Progesterone Supplementation to avoid the premature delivery will also boost the growth of preterm birth prevention and management market. Stringent regulatory scenario for the drug approval to treat the pregnant women will deter the growth of preterm birth prevention and management market to some extent.
Preterm Birth Prevention and Management Market: Segmentation
The global Preterm Birth Prevention and Management market is classified on the basis of treatment type, distribution channel, and geographic region.
Based on treatment type, Preterm Birth Prevention and Management market is segmented into following:
- Tocolytic Therapy
- Progesterone Supplementation
Based on distribution channel, Preterm Birth Prevention and Management market is segmented into following:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Preterm Birth Prevention and Management Market: Overview
Preterm Birth Prevention and Management market is expected show exponential growth over the forecast owing to rising incidences of premature birth. According to WHO, the rate of preterm birth ranges from 5% to 18% of babies born across the 184 countries throughout the globe. Among all the preterm birth, 60% of cases happen only in South Asia and Africa but preterm birth is actually a global issue. More than 90% of extremely preterm babies born in low-income countries die within the first few days of life; yet less than 10% of extremely preterm babies die in high-income settings.
In 2015, WHO has developed new guidelines with recommendations for improving outcomes of preterm births. By treatment type, Progesterone Supplementation is expected to gain more traction for Preterm Birth Prevention and Management market over the forecast period. Among all distribution channel hospital pharmacies expected to gain maximum market share for Preterm Birth Prevention and Management market.
Preterm Birth Prevention and Management Market: Regional Overview
Based on geographic region Preterm Birth Prevention and Management market is classified into seven key regions, North, America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East and Africa. North America is expected to dominate the global Preterm Birth Prevention and Management market due to a large number of preterm birth in this region. After North America, Preterm Birth Prevention and Management market is followed by Western Europe owing to advancement in technology and development of new drugs. In APEJ region India and China is will dominate Preterm Birth Prevention and Management market due to rising incidences of preterm birth.
Preterm Birth Prevention and Management Market: Key Players
Some of player across the value chain of Preterm Birth Prevention and Management market are Aquatic Remedies Pvt. Ltd., Teva Pharmaceuticals USA, Inc., Anglo French Drugs & Industries Limited, Biophar Lifesciences Pvt. Ltd., Jasco Labs (P) Ltd., BSA Pharma Inc. and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-6457
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape
Centrifugal Blood Pump Market – A slew of cardiovascular products were launched for the management of cardiac disorders over the last decade and development of more are currently underway. With leading manufacturers expecting the demand to surge amid COVID-19, centrifugal blood pump sales are set to grow steadily through 2030.
Pharmaceutical Intermediates Market – The global diabetes prevalence in 2019 is estimated to be 9.3% (463 million people), rising to 10.2% (578 million) by 2030, and the number is rising rapidly. Pharmaceutical drugs have remained key to management of chronic diseases and other diseases.
Respiratory Inhaler Devices Market – A slew of new drugs were launched for the management of asthma and COPD over the last decade and development of more are currently underway. With leading drug manufacturers expecting the demand to surge amid COVID-19, respiratory inhaler sales are set to grow steadily through 2030.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org